Edwards Lifesciences Corporation (EW)
USD 72.81
(-1.77%)
USD 72.81
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 895.8 Million | 1.21 Billion | 1.73 Billion | 1.05 Billion | 1.17 Billion | 926.8 Million |
| Net Income | 1.39 Billion | 1.52 Billion | 1.5 Billion | 823.4 Million | 1.04 Billion | 722.2 Million |
| Depreciation & Amortization | 144.9 Million | 139.6 Million | 134.8 Million | 107.2 Million | 89.3 Million | 77.4 Million |
| Deferred income taxes | -272.1 Million | -254.5 Million | -41.4 Million | -49.4 Million | 12.1 Million | -27.3 Million |
| Stock-based compensation | 139.4 Million | 126.8 Million | 109.3 Million | 92.6 Million | 81.3 Million | 71 Million |
| Change in working capital | -526.3 Million | -421.4 Million | 145.3 Million | 42.2 Million | -204.3 Million | -42.6 Million |
| Other non-cash items | 10.5 Million | 105.8 Million | -119 Million | 38.3 Million | 154.1 Million | 126.1 Million |
| Investing Cash Flow | 173.8 Million | 252.3 Million | -1.72 Billion | -531.1 Million | -595.8 Million | 76.7 Million |
| Investments in PPE | -266.3 Million | -264.8 Million | -329.8 Million | -407.3 Million | -278.4 Million | -241.7 Million |
| Acquisitions | -95.2 Million | - | 329.8 Million | 407.3 Million | -100.2 Million | -6.2 Million |
| Investment purchases | -105.5 Million | -778.9 Million | -1.89 Billion | -861.7 Million | -603.1 Million | -471.9 Million |
| Sales/Maturities of investments | 715.8 Million | 1.35 Billion | 529.2 Million | 777 Million | 409.9 Million | 801.3 Million |
| Other Investing Activities | -75 Million | -63.1 Million | -359.3 Million | -446.4 Million | -24 Million | -4.8 Million |
| Financing Cash Flow | -711 Million | -1.58 Billion | -356.3 Million | -486.9 Million | -115.6 Million | -1.1 Billion |
| Debt repayment | -300 Thousand | -200 Thousand | -7 Million | -17 Million | -10 Million | -1.12 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -879.6 Million | -1.72 Billion | -512.8 Million | -625.4 Million | -263.3 Million | -795.5 Million |
| Common Stock Issuance | 169.9 Million | 146.4 Million | 158.6 Million | 140.5 Million | 160.5 Million | 147 Million |
| Other Financing Activities | 168.9 Million | 142.8 Million | 163.5 Million | 155.5 Million | 157.7 Million | 1.36 Billion |
| Accounts receivables | -141.2 Million | -84.1 Million | -112.4 Million | 283.9 Million | -94.8 Million | -13 Million |
| Accounts payables | 146 Million | -21.4 Million | 195.2 Million | -84.5 Million | -63.5 Million | 192.5 Million |
| Inventory | -289 Million | -213.4 Million | 19 Million | -120.6 Million | -105.4 Million | -65.7 Million |
| Other working capital | -242.1 Million | -102.5 Million | 43.5 Million | -36.6 Million | 59.4 Million | -156.4 Million |
| Cash at beginning of period | 772.6 Million | 867.4 Million | 1.2 Billion | 1.18 Billion | 714.1 Million | 818.3 Million |
| Cash at end of period | 1.14 Billion | 772.6 Million | 867.4 Million | 1.2 Billion | 1.17 Billion | 714.1 Million |
| Capital Expenditure | -266.3 Million | -264.8 Million | -329.8 Million | -407.3 Million | -278.4 Million | -241.7 Million |
| Effect of forex changes on cash | 16.8 Million | 19.2 Million | 13.9 Million | -20.5 Million | -3 Million | -6.5 Million |
| Net cash flow / Change in cash | 375.4 Million | -94.8 Million | -332.8 Million | 15.8 Million | 465 Million | -104.2 Million |
| Free Cash Flow | 629.5 Million | 953.4 Million | 1.4 Billion | 647 Million | 901 Million | 685.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 367.7 Million | 351 Million | 369.7 Million | 1.39 Billion | 383.7 Million | 305.5 Million |
| Depreciation & Amortization | 39.6 Million | 38.5 Million | 36.7 Million | 144.9 Million | 36.9 Million | 36.1 Million |
| Deferred income taxes | -66.09 Million | -35.8 Million | -91.4 Million | -272.1 Million | -46 Million | -82.9 Million |
| Stock-based compensation | 43.9 Million | 44.6 Million | 30.5 Million | 139.4 Million | 32.6 Million | 37.4 Million |
| Change in working capital | -20.8 Million | -459 Million | -216.1 Million | -526.3 Million | -12.2 Million | -241.4 Million |
| Other non-cash items | 49.7 Million | 7.2 Million | 7.2 Million | 10.5 Million | 16.5 Million | -21.1 Million |
| Investing Cash Flow | 124.8 Million | 63.1 Million | 14.1 Million | 173.8 Million | 89 Million | 70.2 Million |
| Investments in PPE | -85.4 Million | -85.3 Million | -101.6 Million | -266.3 Million | -55.3 Million | -47.9 Million |
| Acquisitions | - | - | 46 Million | -95.2 Million | 55.3 Million | 47.9 Million |
| Investment purchases | -13.3 Million | -13.4 Million | -58.6 Million | -105.5 Million | -9.6 Million | -6.6 Million |
| Sales/Maturities of investments | 247 Million | 166.6 Million | 137.4 Million | 715.8 Million | 180.4 Million | 134.1 Million |
| Other Investing Activities | -23.5 Million | -4.8 Million | -9.1 Million | -75 Million | -81.8 Million | -57.3 Million |
| Financing Cash Flow | -96.6 Million | 61.7 Million | -413.2 Million | -711 Million | -143.3 Million | 52.1 Million |
| Debt repayment | - | - | -300 Thousand | -300 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -158.1 Million | -200 Thousand | -448.4 Million | -879.6 Million | -174.4 Million | -7.5 Million |
| Common Stock Issuance | 54.3 Million | 62.1 Million | 33.2 Million | 169.9 Million | 34 Million | 60.8 Million |
| Other Financing Activities | 7.2 Million | -200 Thousand | 35.2 Million | 168.9 Million | -2.9 Million | -1.2 Million |
| Accounts receivables | 23 Million | -55 Million | -41.3 Million | -141.2 Million | -28.4 Million | -224.2 Million |
| Accounts payables | 151.8 Million | -89.1 Million | 33.4 Million | 146 Million | 36.4 Million | 121.4 Million |
| Inventory | -94.2 Million | -69.5 Million | -99.3 Million | -289 Million | -76 Million | -80.9 Million |
| Other working capital | -101.4 Million | -267.3 Million | -108.9 Million | -242.1 Million | 55.8 Million | -57.7 Million |
| Cash at beginning of period | 1.22 Billion | 1.14 Billion | 1.41 Billion | 772.6 Million | 1.04 Billion | 876.4 Million |
| Cash at end of period | 1.64 Billion | 1.22 Billion | 1.14 Billion | 1.14 Billion | 1.41 Billion | 1.04 Billion |
| Capital Expenditure | -85.4 Million | -85.3 Million | -101.6 Million | -266.3 Million | -55.3 Million | -47.9 Million |
| Effect of forex changes on cash | 29.4 Million | 9.7 Million | -3.4 Million | 16.8 Million | 9.2 Million | 15.2 Million |
| Net cash flow / Change in cash | 419.8 Million | 81 Million | -265.9 Million | 375.4 Million | 366.4 Million | 171.1 Million |
| Free Cash Flow | 286.1 Million | -138.8 Million | 35 Million | 629.5 Million | 356.2 Million | -14.3 Million |
PLAOU
PYOIF
STAR
9900
9966
GRL